Brind.

Santiago Arroyo was appointed as a Non-Executive Director, and his career history includes work at Pfizer, Bristol Myers Squibb, Eisai, and Schwarz Pharma.

1 report, 1 independent Updated Aug 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Santiago Arroyo was appointed as a Non-Executive Director, and his career history includes work at Pfizer, Bristol Myers Squibb, Eisai, and Schwarz Pharma.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireMaxion Therapeutics Strengthens Board with Appointment of Dr. Santiago Arroyo as a Non-Executive Director Cambridge, UK, 27 August 2025 – Maxion Therapeutics (“Maxion”), a biotechnology company devel